Clinical Trial Update: Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis [Phase 4]

View source ↗

Summary

Phase 4 trial of topical 2% ganciclovir eye drops for CMV anterior uveitis and endotheliitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis
• Cytomegalovirus Infections
• Endotheliitis

Drugs mentioned

• Ganciclovir ophthalmic solution 2% (ganciclovir)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Cytomegalovirus Infections | Phase 4 | Status: COMPLETED